Cargando…
Cost-effectiveness of talazoparib for patients with locally advanced or metastasized breast cancer in Germany
This study evaluated factors that influence the cost-effectiveness of talazoparib, particularly for patients with a germline breast-cancer-gene-(brca)-mutation and locally advanced or metastasized breast cancer within the context of the German healthcare system. We constructed a partitioned survival...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714746/ https://www.ncbi.nlm.nih.gov/pubmed/36454738 http://dx.doi.org/10.1371/journal.pone.0278460 |